EGFR exon 20 insertion mutation in advanced thymic squamous cell carcinoma: Response to apatinib and clinical outcomes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EGFR
exon 20 insertion mutation in advanced thymic squamous cell carcinoma: Response to apatinib and clinical outcomes
Authors
Keywords
-
Journal
Thoracic Cancer
Volume 9, Issue 7, Pages 885-891
Publisher
Wiley
Online
2018-05-09
DOI
10.1111/1759-7714.12755
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
- (2018) Giuseppe Giaccone et al. LANCET ONCOLOGY
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
- (2016) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Antiangiogenic therapy in oncology: current status and future directions
- (2016) Gordon C Jayson et al. LANCET
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome of nonsurgical treatment for locally advanced thymic tumors
- (2016) Chang-Lu Wang et al. Journal of Thoracic Disease
- PD-1/PD-L1 inhibitors
- (2015) Joel Sunshine et al. CURRENT OPINION IN PHARMACOLOGY
- Pemetrexed in patients with thymic malignancies previously treated with chemotherapy
- (2015) Ying Liang et al. LUNG CANCER
- Prevalence, Clinicopathologic Characteristics, and Molecular Associations of EGFR Exon 20 Insertion Mutations in East Asian Patients with Lung Adenocarcinoma
- (2014) Yunjian Pan et al. ANNALS OF SURGICAL ONCOLOGY
- Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy
- (2014) Yusuke Okuma et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Thymic Carcinoma, Part 1
- (2012) Annikka Weissferdt et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Rare thoracic cancers, including peritoneum mesothelioma
- (2012) Sabine Siesling et al. EUROPEAN JOURNAL OF CANCER
- Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice
- (2012) F. Lignet et al. JOURNAL OF THEORETICAL BIOLOGY
- Signal transduction by vascular endothelial growth factor receptors
- (2011) Sina Koch et al. BIOCHEMICAL JOURNAL
- Thymic Tumors: Relevant Molecular Data in the Clinic
- (2010) Nicolas Girard Journal of Thoracic Oncology
- Epidemiology of Thymoma and Associated Malignancies
- (2010) Eric A. Engels Journal of Thoracic Oncology
- Comparison of patterns of relapse in thymic carcinoma and thymoma
- (2009) James Huang et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus
- (2008) Anca Maria Cimpean et al. ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER
- Thymic epithelial tumours: A population-based study of the incidence, diagnostic procedures and therapy
- (2007) Wouter K. de Jong et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now